What is the advantage of glycopeptide analysis compared to released glycan profiling?

Glycopeptide analysis provides site-specific glycosylation mapping, revealing exactly which glycan structures occupy each attachment site. This localization is indispensable for characterizing multi-site antibodies or bispecific molecules where glycosylation at specific domains directly impacts function.

What is your approach for analyzing heavily glycosylated antibodies like IgM or IgA?

For complex isotypes, we deploy customized enzymatic digestion panels coupled with targeted enrichment protocols, which are specifically optimized to achieve comprehensive glycosylation mapping across high-density sites.

Therapeutic Antibody Glycopeptide Analysis Service

Background Service What We Can Offer Workflow Highlights FAQs Contact

Conventional glycan analysis falls short by obscuring the location-specific glycosylation details crucial for evaluating how structural variations influence a therapeutic antibody's safety profile, functional potency, and in vivo behavior. Creative Biolabs' Therapeutic Antibody Glycopeptide Analysis Service provides precise, site-resolved glycosylation mapping for your molecules. We deploy a robust platform integrating high-sensitivity LC-MS glycopeptide mapping with proprietary informatics to quantify glycan structures at each attachment site. Our service delivers actionable, site-specific data, such as Fc/Fab differentiation and critical quality attribute indices, enabling you to de-risk development, streamline comparability studies, and build a stronger regulatory package with confidence.

Introduction

Glycosylation is a critical quality attribute of therapeutic antibodies, directly impacting their safety, efficacy, and pharmacokinetics. However, traditional released glycan analysis aggregates all glycans, losing essential site-specific information, especially for molecules with multiple glycosylation sites or bispecific formats. This limitation hinders precise risk assessment of critical attributes such as effector function, immunogenicity, and clearance. To address this, advanced glycopeptide analysis has emerged as a superior approach, enabling site-resolved glycosylation mapping. This method preserves the localization of glycan structures, such as those on Fc versus Fab domains, and facilitates the calculation of quantitative, site-specific glycosylation indices. These metrics deliver a uniform, holistic molecular fingerprint essential for demonstrating batch comparability, optimizing manufacturing processes, and mitigating development risks, thereby translating intricate glycosylation data into actionable insights for regulatory success.

Fig.1 Domain-specific glycan analysis of complex glycoproteins. (OA Literature) Fig.1 Comprehensive glycan profiling of a multi-domain glycoprotein. 1

Therapeutic Antibody Glycopeptide Analysis Service at Creative Biolabs

Creative Biolabs' Therapeutic Antibody Glycopeptide Analysis Service delivers an integrated analytical platform that fully characterizes both the global and site-specific glycosylation profiles of antibody therapeutics. Moving beyond conventional glycan analysis, our service definitively associates distinct carbohydrate motifs with their precise protein localization. This enables targeted monitoring of glycoforms that critically modulate effector functions such as antibody-dependent cellular cytotoxicity (ADCC).

What We Can Offer

Our service offers a complete solution for antibody glycan characterization, combining site-specific glycopeptide mapping with advanced sample preparation to deliver actionable, in-depth glycosylation data for your development needs.

Featured services of the therapeutic antibody glycopeptide analysis service at Creative Biolabs. (Creative Biolabs Original)

In addition to our Therapeutic Antibody Glycopeptide Analysis, our Site-Specific Glycoform Analysis Services provide an end-to-end solution, from precise glycosylation site mapping to functional correlation analysis, enabling you to comprehensively deconvolute glycoform heterogeneity, optimize biologic efficacy, and accelerate rational design and process development.

Our Service Process

Required Starting Materials:

Purified Antibody Sample: Minimum 50-100 µg of the monoclonal antibody (mAb) or Fc-fusion protein.
Sequence Information: The theoretical primary protein sequence to facilitate accurate peptide mapping and mass matching.

Key Steps:

Workflow of therapeutic antibody glycopeptide analysis service at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables:

Comprehensive Site-Specific Glyco-Map.
Raw MS Data & Annotations.

Key Advantages

Unmatched Analytical Sensitivity: Our platform reliably characterizes glycopeptides down to picomolar concentrations, making it uniquely suited for analyzing scarce early-development samples.
Methodologically Robust & QbD-Aligned: All analytical workflows are developed and executed under Quality-by-Design (QbD) frameworks, guaranteeing data integrity, reproducibility, and compliance readiness.
Dedicated Scientific Partnership: Clients benefit from direct collaboration with our expert scientists, who provide in-depth data interpretation and help establish critical links between glycan structures and their functional activity.

FAQs

Q1: What is the advantage of glycopeptide analysis compared to released glycan profiling?
A1: Glycopeptide analysis provides site-specific glycosylation mapping, revealing exactly which glycan structures occupy each attachment site. This localization is indispensable for characterizing multi-site antibodies or bispecific molecules where glycosylation at specific domains directly impacts function.
Q2: What is your approach for analyzing heavily glycosylated antibodies like IgM or IgA?
A2: For complex isotypes, we deploy customized enzymatic digestion panels coupled with targeted enrichment protocols, which are specifically optimized to achieve comprehensive glycosylation mapping across high-density sites.

Why Choose Us?

Creative Biolabs delivers actionable insights, not just data. Our proprietary platform combines ultrasensitive microfluidics with deep biological expertise to map site-specific glycosylation, even on scarce samples. We transform complex glycopeptide analysis into clear, functional guidance on critical attributes like pharmacokinetics and immunogenicity, accelerating your candidate's path to clinic.

Customer Reviews

"The detailed glycopeptide profiling was pivotal for advancing our bispecific antibody program. By accurately distinguishing Fc and Fab glycosylation patterns, it substantially strengthened the technical foundation of our Chemistry, Manufacturing, and Controls (CMC) documentation." Dr. A* son.

"Implementing their HPLC-Chip platform dramatically increased the sensitivity for detecting trace-level glycopeptides. The automated data analysis provided highly accurate results, condensing a process that traditionally required weeks of manual interpretation into a matter of days." Prof. M* rk.

"This service has been essential for addressing regulatory questions on glycosylation profiles. The implementation of a dual-verification methodology yielded definitive structural characterization data, eliminating any uncertainty for our agency communications." L* na S.

How to contact us?

Ready to gain precise, site-specific glycosylation insights that de-risk your antibody development? Our team of dedicated Ph.D.-level scientists is available to provide a custom project consultation, detailed service quote, and strategic guidance tailored to your specific therapeutic candidate. Connect with us today to discuss how our advanced analytics can streamline your path to CMC and regulatory success.

Reference

Mastrangeli, Renato et al. "Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics." Molecules (Basel, Switzerland) vol. 28,8 3304. Distributed under an Open Access License CC BY 4.0, without modification. https://doi.org/10.3390/molecules28083304.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: